Does aortic valve replacement improve outcomes in patients with severe aortic regurgitation and markedly reduced left ventricular function?
AVR provides significant long-term survival and EF improvement in patients with severe AR and markedly reduced EF, despite elevated operative risks, indicating these patients should not be denied surgery.
Patients with severe AR and markedly low EF incur excess operative mortality rates, postoperative mortality rates, and congestive heart failure after AVR. However, postoperative EF improves markedly, and most patients enjoy a long postoperative survival without recurrence of heart failure after AVR; thus they should not be denied the benefits of AVR.
Chaliki et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: